Category finalist: Most Innovative Service or Technology Supporting F&B
AMBROSIA’s proprietary, disruptive enzyme technology platform is designed to convert high-calorie, obesity-promoting sugars into both rare, practically no-calorie sugars, such as Allulose and into dietary fibers. A significant health benefit of these rare sugars’ close-to-nil caloric value is negligible on blood glucose levels and insulin spikes. Globally-expanding clinical research demonstrates that converting as little as 5–10% of high-calorie sugars into these rare sugars will significantly improve health.
WatchAMBROSIA's pitch from Fi Europe 2021, co-located with Hi Europe to learn more about how this startup is leveraging technology to convert high-calorie sugars into practically no-calorie sugars.Â
Speaker
Dr. Ziv Zwighaft, Founder & CEO
Ziv Zwighaft is an experienced co-founder, with a demonstrated history of working in the biotechnology industry. Ziv is skilled in sales, molecular biology, management, leadership, and life sciences. He is a strong business development professional with a Ph.D. degree focused in Biochemistry from Weizmann Institute of Science, and an MBA from Reichman University, (IDC Herzliya). In addition, Ziv is an avid ultra-marathon runner competitor.